Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 83.85%
March 31, 2026 2.39%
December 31, 2025 -3.79%
September 30, 2025 1.67%
June 30, 2025 -9.88%
March 31, 2025 -12.23%
December 31, 2024
September 30, 2024 -12.83%
June 30, 2024 -5.01%
March 31, 2024 -27.60%
December 31, 2023 -180.1%
September 30, 2023 -34.95%
June 30, 2023 -35.49%
March 31, 2023 -30.74%
December 31, 2022 -22.25%
September 30, 2022 -21.34%
June 30, 2022 -26.91%
March 31, 2022 -24.74%
December 31, 2021 -20.39%
September 30, 2021 -15.74%
June 30, 2021 -2.60%
March 31, 2021 -1.02%
December 31, 2020 -5.99%
September 30, 2020 -5.28%
June 30, 2020 -15.69%
Date Value
March 31, 2020 -15.17%
December 31, 2019 -13.34%
September 30, 2019 -5.36%
June 30, 2019 -24.95%
March 31, 2019 -28.99%
December 31, 2018 -15.97%
September 30, 2018 -94.27%
June 30, 2018 -78.90%
March 31, 2018 -64.00%
December 31, 2017 -253.0%
September 30, 2017 -117.2%
June 30, 2017 -33.50%
March 31, 2017 -48.42%
December 31, 2016 -144.7%
September 30, 2016 -30.45%
June 30, 2016 -97.75%
March 31, 2016 -148.6%
December 31, 2015 -71.63%
September 30, 2015 -48.79%
June 30, 2015 -44.68%
March 31, 2015 -31.49%
December 31, 2014 -0.07%
September 30, 2014 18.23%
June 30, 2014 12.94%
March 31, 2014 -22.01%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Natera, Inc. -8.90%
Caris Life Sciences, Inc. -0.24%
Myriad Genetics, Inc. -22.65%
BioRestorative Therapies, Inc. -9.29K%
Exagen, Inc. -16.03%